Complement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile Virus

被引:89
作者
Mehlhop, Erin [1 ]
Nelson, Steevenson [4 ]
Jost, Christiane A. [4 ]
Gorlatov, Sergey [5 ]
Johnson, Syd [5 ]
Fremont, Daved H. [1 ]
Diamond, Michael S. [1 ,2 ,3 ]
Pierson, Theodore C. [4 ]
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
[4] NIH, Viral Pathogenesis Sect, Viral Dis Lab, Bethesda, MD 20892 USA
[5] MacroGenics Inc, Rockville, MD 20850 USA
基金
美国国家卫生研究院;
关键词
HUMANIZED MONOCLONAL-ANTIBODY; FC-GAMMA RECEPTORS; YELLOW-FEVER VIRUS; DENGUE VIRUS; DEPENDENT ENHANCEMENT; ENVELOPE GLYCOPROTEIN; FLAVIVIRUS INFECTION; ADAPTIVE IMMUNITY; CRYSTAL-STRUCTURE; ENCEPHALITIS-VIRUS;
D O I
10.1016/j.chom.2009.09.003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Virus neutralization is governed by the number of antibodies that bind a virion during the cellular entry process. Cellular and serum factors that interact with antibodies have the potential to modulate neutralization potency. Although the addition of serum complement can increase the neutralizing activity of antiviral antibodies in vitro, the mechanism and significance of this augmented potency in vivo remain uncertain. Herein, we show that the complement component C1q increases the potency of antibodies against West Nile virus by modulating the stoichiometric requirements for neutralization. The addition of C1q does not result in virolysis but instead reduces the number of antibodies that must bind the virion to neutralize infectivity. For IgG subclasses that bind C1q avidly, this reduced stoichiometric threshold falls below the minimal number of antibodies required for antibody-dependent enhancement (ADE) of infection of cells expressing Fc-gamma receptors (CD32) and explains how C1q restricts the ADE of flavivirus infection.
引用
收藏
页码:381 / 391
页数:11
相关论文
共 76 条
[1]  
Andrewes CH, 1933, BRIT J EXP PATHOL, V14, P367
[2]   Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice [J].
Ben-Nathan, D ;
Lustig, S ;
Tam, G ;
Robinzon, S ;
Segal, S ;
Rager-Zisman, B .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (01) :5-12
[3]   Vaccinia Virus Extracellular Enveloped Virion Neutralization In Vitro and Protection In Vivo Depend on Complement [J].
Benhnia, Mohammed Rafii-El-Idrissi ;
McCausland, Megan M. ;
Moyron, Juan ;
Laudenslager, John ;
Granger, Steven ;
Rickert, Sandra ;
Koriazova, Lilia ;
Kubo, Ralph ;
Kato, Shinichiro ;
Crotty, Shane .
JOURNAL OF VIROLOGY, 2009, 83 (03) :1201-1215
[4]   HUMAN MONOCLONAL IGG ISOTYPES DIFFER IN COMPLEMENT ACTIVATING FUNCTION AT THE LEVEL OF C-4 AS WELL AS CLQ [J].
BINDON, CI ;
HALE, G ;
BRUGGEMANN, M ;
WALDMANN, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (01) :127-142
[5]   Role of dendritic cells in antibody-dependent enhancement of dengue virus infection [J].
Boonnak, Kobporn ;
Slike, Bonnie M. ;
Burgess, Timothy H. ;
Mason, Randall M. ;
Wu, Shuenn-Jue ;
Sun, Peifang ;
Porter, Kevin ;
Rudiman, Irani Fianza ;
Yuwono, Djoko ;
Puthavathana, Pilaipan ;
Marovich, Mary A. .
JOURNAL OF VIROLOGY, 2008, 82 (08) :3939-3951
[6]  
Burnet F. M., 1937, Australian Journal of Experimental Biology and Medical Science, V15, P227, DOI 10.1038/icb.1937.23
[7]   IMMUNOGLOBULIN-G - FUNCTIONAL SITES [J].
BURTON, DR .
MOLECULAR IMMUNOLOGY, 1985, 22 (03) :161-206
[8]   Antibodies, viruses and vaccines [J].
Burton, DR .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (09) :706-713
[9]  
Burton DR, 2001, CURR TOP MICROBIOL, V260, P109
[10]   The complement system in regulation of adaptive immunity [J].
Carroll, MC .
NATURE IMMUNOLOGY, 2004, 5 (10) :981-986